ENERZAIR BREEZHALER

Identification of Enerzair Breezhaler

No description

Google image searchProduct monograph

Active ingredients

indacaterol (indacaterol acetate), 150 MCG

glycopyrronium (glycopyrronium bromide), 50 MCG

mometasone furoate, 160 MCG

DIN: 02501244

Dosage form(s): CAPSULE

Route(s) of administration: INHALATION

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 05-NOV-2020

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03A — ADRENERGICS, INHALANTS (ATC, ATC/DDD)
• R03AL — Adrenergics in combination with anticholinergics (ATC, ATC/DDD)
• R03AL12 — INDACATEROL, GLYCOPYRRONIUM BROMIDE AND MOMETASONE (ATC/DDD)

External Links for Enerzair Breezhaler

Search on Google

• Enerzair Breezhaler side effects
• Enerzair Breezhaler dosage
• indacaterol side effects
• indacaterol dosage
• glycopyrronium side effects
• glycopyrronium dosage
• mometasone furoate side effects
• mometasone furoate dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find enerzair breezhaler photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.